Scandinavian Clinical Nutrition: Strong Results against Influenza in New SCN Study At Louisiana State University

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Recent studies show that SCN’s (OSE:SCN) patented and trademark protected immune stimulating product Immulina gives good protection against the influenza virus H1N1, similar to the ‘bird flu’ virus H5N1. The financial potential of this is significant, as the results may enable new virus treatments and ways to strengthen the immune system in both humans and animals.

Back to news